In vivo vascular hallmarks of diffuse leukoaraiosis

Journal of Magnetic Resonance Imaging

Volumn 32, Issue 1, 2010, Pages 184-190

  Uh, Jinsoo ^a   Yezhuvath, Uma ^a   Cheng, Yamei ^a   Lu, Hanzhang ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Blood brain barrier; Cerebral blood flow; Cerebrovascular reactivity; Leukoaraiosis; Vascular changes

Indexed keywords

AGED; ARTICLE; BLOOD BRAIN BARRIER LEAKAGE; BRAIN BLOOD FLOW; BRAIN REGION; CARDIOVASCULAR PARAMETERS; CEREBROVASCULAR DISEASE; CEREBROVASCULAR REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSE LEUKOARAIOSIS; DIFFUSION TENSOR IMAGING; FEMALE; FLUID ATTENUATED INVERSION RECOVERY MAGNETIC RESONANCE IMAGING; HUMAN; IN VIVO STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATTERN RECOGNITION; PRIORITY JOURNAL; VASCULAR LESION; WHITE MATTER; BLOOD BRAIN BARRIER; BLOOD FLOW VELOCITY; BRAIN; BRAIN CIRCULATION; BRAIN MAPPING; CROSS-SECTIONAL STUDY; IMAGE PROCESSING; LEUKOARAIOSIS; PATHOLOGY; PROCEDURES; VASCULARIZATION;

AGED; BLOOD FLOW VELOCITY; BLOOD-BRAIN BARRIER; BRAIN; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEUKOARAIOSIS; MAGNETIC RESONANCE IMAGING; MALE;

EID: 77954138586     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22209     Document Type: Article

References (56)

1. O'Sullivan M. Leukoaraiosis. Pract Neurol 2008;8:26-38.
2. Essig M, Hawighorst H, Schoenberg SO, et al. Fast fluid-attenuated inversion-recovery (FLAIR) MRI in the assessment of intraaxial brain tumors. J Magn Reson Imaging 1998;8:789-798. (Pubitemid 28357585)
3. Liu CK, Miller BL, Cummings JL, et al. A quantitative MRI study of vascular dementia. Neurology 1992;42:138-143.
4. Gootjes L, Teipel SJ, Zebuhr Y, et al. Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging. Dement Geriatr Cogn Disord 2004;18:180-188.
5. Basile AM, Pantoni L, Pracucci G, et al. Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes. The LADIS (Leukoaraiosis and Disability in the Elderly) Study. Cerebrovasc Dis 2006;21:315-322.
6. Dufouil C, de Kersaint-Gilly A, Besancon V, et al. Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. Neurology 2001;56:921-926. (Pubitemid 32290809)
7. Liao D, Cooper L, Cai J, et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. Stroke 1996;27:2262-2270.
8. Hainsworth AH, Markus HS. Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review. J Cereb Blood Flow Metab 2008;28:1877-1891.
9. Schmidt R, Scheltens P, Erkinjuntti T, et al. White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease. Neurology 2004;63:139-144. (Pubitemid 38943791)
10. Wiszniewska M, Devuyst G, Bogousslavsky J, Ghika J, van Melle G. What is the significance of leukoaraiosis in patients with acute ischemic stroke? Arch Neurol 2000;57:967-973.
11. Bots ML, van Swieten JC, Breteler MM, et al. Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet 1993;341:1232-1237.
12. Smith EE, Gurol ME, Eng JA, et al. White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage. Neurology 2004;63:1606-1612. (Pubitemid 39507576)
13. Guttmann CR, Jolesz FA, Kikinis R, et al. White matter changes with normal aging. Neurology 1998;50:972-978. (Pubitemid 28212824)
14. Schmidt R, Schmidt H, Kapeller P, et al. The natural course of MRI white matter hyperintensities. J Neurol Sci 2002;203-204:253-257. (Pubitemid 35287407)
15. Kraut MA, Beason-Held LL, Elkins WD, Resnick SM. The impact of magnetic resonance imaging-detected white matter hyperintensities on longitudinal changes in regional cerebral blood flow. J Cereb Blood Flow Metab 2008;28:190-197.
16. Piguet O, Ridley L, Grayson DA, et al. Are MRI white matter lesions clinically significant in the 'old-old'? Evidence from the Sydney Older Persons Study. DementGeriatr CognDisord 2003;15:143-150. (Pubitemid 36206643)
17. Soderlund H, Nyberg L, Adolfsson R, Nilsson LG, Launer LJ. High prevalence of white matter hyperintensities in normal aging: relation to blood pressure and cognition. Cortex 2003;39:1093-1105.
18. Wen W, Sachdev P. The topography of white matter hyperintensities on brain MRI in healthy 60- to 64-year-old individuals. Neuroimage 2004;22:144-154.
19. Yue NC, Arnold AM, Longstreth WT Jr, et al. Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: data from the cardiovascular health study. Radiology 1997;202:33-39.
20. Breteler MM, van Swieten JC, Bots ML, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 1994;44:1246-1252.
21. Gunning-Dixon FM, Raz N. The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. Neuropsychology 2000;14:224-232.
22. Lammie GA. Pathology of small vessel stroke. Br Med Bull 2000;56:296-306.
23. Lammie GA, Brannan F, Slattery J, Warlow C. Nonhypertensive cerebral small-vessel disease. An autopsy study. Stroke 1997;28:2222-2229.
24. Akiguchi I, Tomimoto H, Suenaga T, Wakita H, Budka H. Blood-brain barrier dysfunction in Binswanger's disease; an immunohistochemical study. Acta Neuropathol 1998;95:78-84. (Pubitemid 28075930)
25. Wallin A, Sjogren M, Edman A, Blennow K, Regland B. Symptoms, vascular risk factors and blood-brain barrier function in relation to CT white-matter changes in dementia. Eur Neurol 2000;44:229-235.
26. Wardlaw JM, Sandercock PA, Dennis MS, Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 2003;34:806-812.
27. Lu H, Law M, Johnson G, Ge Y, van Zijl PC, Helpern JA. Novel approach to the measurement of absolute cerebral blood volume using vascular-space-occupancy magnetic resonance imaging. Magn Reson Med 2005;54:1403-1411. (Pubitemid 41740770)
28. Dai W, Garcia D, de Bazelaire C, Alsop DC. Continuous fow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med 2008;60:1488-1497.
29. Wong EC. Vessel-encoded arterial spin-labeling using pseudocontinuous tagging. Magn Reson Med 2007;58:1086-1091.
30. Wu WC, Fernandez-Seara M, Detre JA, Wehrli FW, Wang J. A theoretical and experimental investigation of the tagging efficiency of pseudocontinuous arterial spin labeling. Magn Reson Med 2007;58:1020-1027. (Pubitemid 350074370)
31. Yezhuvath US, Lewis-Amezcua K, Varghese R, Xiao G, Lu H. On the assessment of cerebrovascular reactivity using hypercapnia BOLD MRI. NMR Biomed 2009;22:779-786.
32. Lu H, Golay X, Pekar JJ, Van Zijl PC. Functional magnetic resonance imaging based on changes in vascular space occupancy. Magn Reson Med 2003;50:263-274. (Pubitemid 36950845)
33. Lu H, Pollack E, Young R, et al. Predicting grade of cerebral glioma using vascular-space occupancy MR imaging. AJNR Am J Neuroradiol 2008;29:373-378. (Pubitemid 351287899)
34. Lu H, Clingman C, Golay X, van Zijl PC. Determining the longitudinal relaxation time (T1) of blood at 3.0 Tesla. Magn Reson Med 2004;52:679-682.
35. Jones DK, Horsfield MA, Simmons A. Optimal strategies for measuring diffusion in anisotropic systems by magnetic resonance imaging. Magn Reson Med 1999;42:515-525.
36. Brant-Zawadzki M, Gillan GD, Nitz WR. MP RAGE: a three-dimensional, T1-weighted, gradient-echo sequence-initial experience in the brain. Radiology 1992;182:769-775.
37. Marquez de la Plata C, Ardelean A, Koovakkattu D, et al. Magnetic resonance imaging of diffuse axonal injury: quantitative assessment of white matter lesion volume. J Neurotrauma 2007;24:591-598.
38. Aslan S, Xu F, Wang PL, et al. Estimation of labeling efficiency in pseudocontinuous arterial spin labeling. Magn Reson Med 2010;63:765-771.
39. van Osch MJ, Teeuwisse WM, van Walderveen MA, Hendrikse J, Kies DA, van Buchem MA. Can arterial spin labeling detect white matter perfusion signal? Magn Reson Med 2009;62:165-173.
40. Grubb RL Jr, Raichle ME, Eichling JO, Ter-Pogossian MM. The effects of changes in PaCO2 on cerebral blood volume, blood flow, and vascular mean transit time. Stroke 1974;5:630-639.
41. Hassan A, Hunt BJ, O'Sullivan M, et al. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 2003;126(Pt 2):424-432. (Pubitemid 36172746)
42. Brickman AM, Zahra A, Muraskin J, et al. Reduction in cerebral blood flow in areas appearing as white matter hyperintensities on magnetic resonance imaging. Psychiatry Res 2009;172:117-120.
43. Marstrand JR, Garde E, Rostrup E, et al. Cerebral perfusion and cerebrovascular reactivity are reduced in white matter hyperintensities. Stroke 2002;33:972-976. (Pubitemid 34293577)
44. O'Sullivan M, Lythgoe DJ, Pereira AC, et al. Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology 2002;59:321-326. (Pubitemid 34857922)
45. Sakoglu U, Huisa-Garate B, Rosenberg GA, Sood R. Application of FT-based MMSE deconvolution method for cerebral blood flow measurement in patients with leukoaraiosis. Magn Reson Imaging 2009;27:625-630.
46. Roy CS, Sherrington CS. On the regulation of the blood-supply of the brain. J Physiol 1890;11:85-158.17.
47. Villringer A, Dirnagl U. Coupling of brain activity and cerebral blood flow: basis of functional neuroimaging. Cerebrovasc Brain Metab Rev 1995;7:240-276.
48. Bakker SL, de Leeuw FE, de Groot JC, Hofman A, Koudstaal PJ, Breteler MM. Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly. Neurology 1999;52:578-583.
49. Mandell DM, Han JS, Poublanc J, et al. Selective reduction of blood flow to white matter during hypercapnia corresponds with leukoaraiosis. Stroke 2008;39:1993-1998.
50. Holland CM, Smith EE, Csapo I, et al. Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke 2008;39:1127-1133.
51. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke 1997;28:652-659.
52. Topakian R, Barrick TR, Howe FA, Markus HS. Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis. J Neurol Neurosurg Psychiatry 2010;81:192-197.
53. Wardlaw JM, Farrall A, Armitage PA, et al. Changes in background blood-brain barrier integrity between lacunar and cortical ischemic stroke subtypes. Stroke 2008;39:1327-1332. (Pubitemid 351440710)
54. Bastin ME, Clayden JD, Pattie A, Gerrish IF, Wardlaw JM, Deary IJ. Diffusion tensor and magnetization transfer MRI measurements of periventricular white matter hyperintensities in old age. Neurobiol Aging 2009;30:125-136.
55. Nitkunan A, Barrick TR, Charlton RA, Clark CA, Markus HS. Multimodal MRI in cerebral small vessel disease: its relationship with cognition and sensitivity to change over time. Stroke 2008;39:1999-2005.
56. Bastos-Leite AJ, Kuijer JP, Rombouts SA, et al. Cerebral blood flow by using pulsed arterial spin-labeling in elderly subjects with white matter hyperintensities. AJNR Am J Neuroradiol 2008;29:1296-1301.